Hence, we tested the hypothesis that ASP can prevent HG- and hyperglycemia-induced oxidative injury by up-regulating the transcriptional expression of Nrf2 by using an in vitro H9c2 cardiomyocyte model and a leptin receptor-deficient db/db mouse model, respectively. This evidence concerns the gene NFE2L2 and Hyperglycemia.